Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions

Bibliographic Details
Title: Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions
Authors: Ruohui Zheng, Guru R. Valicherla, Junmei Zhang, Jeremy Nuttall, Peter Silvera, Leslie J. Marshall, Philip E. Empey, Lisa C. Rohan
Source: Pharmaceutics, Vol 14, Iss 9, p 1948 (2022)
Publisher Information: MDPI AG, 2022.
Publication Year: 2022
Collection: LCC:Pharmacy and materia medica
Subject Terms: dapivirine, drug transporters, tissue permeability, drug-drug interactions, HIV, Pharmacy and materia medica, RS1-441
More Details: The dapivirine (DPV) vaginal ring was developed by the nonprofit International Partnership for Microbicides (IPM) for reducing the risk of HIV infection. A clinical study (IPM 028) showed that concomitant use of the DPV ring and miconazole (MIC) altered DPV pharmacokinetic profile. In this work, we investigated whether or not DPV transport and permeation contributed to the observed DPV-MIC interaction. Our study evaluated the interaction between DPV and several transporters that are highly expressed in the human female reproductive tract, including MRP1, MRP4, P-gp, BCRP, and ENT1, using vesicular and cellular systems. We also evaluated the impact of DPV/MIC on cellular tight junctions by monitoring transepithelial electrical resistance with the Ussing chamber. Lastly, we evaluated the effect of MIC on DPV permeability across human cervical tissue. Our findings showed that DPV was not a substrate of MRP1, MRP4, P-gp, BCRP, or ENT1 transporters. Additionally, DPV did not inhibit the activity of these transporters. DPV, MIC, and their combination also did not disrupt cellular tight junctions. MIC did not affect DPV tissue permeability but significantly reduced DPV tissue levels. Therefore, our results suggest that the DPV-MIC interaction is not due to these five transporters, altered tight junction integrity, or altered tissue permeability.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1999-4923
Relation: https://www.mdpi.com/1999-4923/14/9/1948; https://doaj.org/toc/1999-4923
DOI: 10.3390/pharmaceutics14091948
Access URL: https://doaj.org/article/e4fb5b9b7a494d1bbd074a70a13b599f
Accession Number: edsdoj.4fb5b9b7a494d1bbd074a70a13b599f
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:19994923
DOI:10.3390/pharmaceutics14091948
Published in:Pharmaceutics
Language:English